Generation X Faces Higher Risk of Methamphetamine-Related Deaths in Australia

A recent study conducted by the Burnet Institute reveals that Australia’s Generation X—those born between 1962 and 1982—are experiencing the highest rates of death related to methamphetamine use compared to other age groups. The research, published in the journal Addiction, analyzed two decades of data from the National Coronial Information System, which records all reported deaths across Australia and New Zealand.

The findings highlight a troubling increase in methamphetamine-related fatalities, including deaths caused by accidental drug toxicity and cardiovascular issues, with the overall number of such deaths more than quadrupling over the past 20 years. This rise coincides with the broader availability of high-purity crystal meth in Australia, particularly from 2013 onward.

While younger Australians have seen a decline in methamphetamine-related deaths, older adults in Generation X are disproportionately affected. Experts attribute this pattern to several factors, including gaps in support services tailored to older users and the pervasive stigma associated with methamphetamine use. Dr. Amanda Roxburgh from Burnet emphasized that the stigma heavily impacts individuals’ willingness to seek help, further increasing their risk.

The study underscores the need for a shift in healthcare approaches, advocating for more inclusive and age-sensitive support systems. Current services tend to focus more on opioid users, leaving many older methamphetamine users underserved. Addressing these disparities is crucial to reducing preventable deaths.

Researcher Oisin Stronach pointed out that the complex nature of these deaths, often involving multiple substances, demands an integrated response. Improving access to health services for all age groups, regardless of the substance used, is a vital step toward mitigating this growing public health concern.

The study highlights the importance of dismantling stigma and ensuring equitable care for all individuals affected by methamphetamine use, aiming to save lives and improve health outcomes in Australia.